SoundHealth develops personalized, AI-enabled, non-invasive medical and wellness devices targeting breathing and sleep disorders. Its flagship FDA-cleared Sonu band has delivered more than 500,000 acoustic resonance treatment sessions for users ages 12 and up and is described as a leading steroid alternative for congestion due to allergic and non-allergic rhinitis. The company has built a craniofacial anatomical dataset used to personalize treatments and to underpin its Spatial Sleep product, which the company says is the world’s first clinically proven personalized sleep wellness device and has been shown to help users fall asleep faster and sleep longer. SoundHealth is recommended by more than 1,000 medical and dental professionals nationwide. Following the Series A, the company has $12.25 million in total funding to date to support further growth and commercialization.

Total raised

$19M

Funding rounds

2

Latest round

Series A

Latest activity

Jul 2026